Johnson & Johnson (JNJ) gets FDA priority review for TAR-200 gains, a drug releasing system targeting bladder cancer. Read ...

Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and ...

Global cheese market advances through functional nutrition, regulatory sustainability, and digital commerce innovation. Traditional dairies embrace p ...

Background Alexander disease is an autosomal dominant leukodystrophy caused by heterozygous pathogenic variants in the glial ...